Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy

被引:3
作者
Aouate, David [1 ]
Menet, Aymeric [1 ]
Bellevre, Dimitri [2 ]
Damy, Thibaud [3 ]
Marechaux, Sylvestre [1 ]
机构
[1] UCLille, Fac Med & Maieut, GCS Grp Hop Inst Catholique Lillois, Cardiol Dept, F-59000 Lille, France
[2] Hop St Philibert, Grp Hop Inst Catholique Lille, Dept Nucl Med, UF 5881, Rue Grand But, F-59160 Lomme Les Lille, France
[3] UPEC, CHU Henri Mondor,U955, DHU A TVB INSERM,GRC Amyloid Res Inst,Clin Invest, Dept Cardiol,Referral Ctr Cardiac Amyloidosis,Mon, Creteil, France
关键词
Cardiac amyloidosis; Heart failure; Resynchronization therapy; Right ventricular pacing Case report; CARDIOVERTER-DEFIBRILLATOR; DIAGNOSIS;
D O I
10.1093/ehjcr/ytaa088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. Cases summary We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). Discussion The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation.
引用
收藏
页数:5
相关论文
共 8 条
[1]   Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years [J].
Barroso, Fabio A. ;
Judge, Daniel P. ;
Ebede, Ben ;
Li, Huihua ;
Stewart, Michelle ;
Amass, Leslie ;
Sultan, Marla B. .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 (03) :194-204
[2]   Identification of prognostic markers in transthyretin and AL cardiac amyloidosis* [J].
Damy, Thibaud ;
Jaccard, Arnaud ;
Guellich, Aziz ;
Lavergne, David ;
Galat, Arnault ;
Deux, Jean-Francois ;
Hittinger, Luc ;
Dupuis, Jehan ;
Frenkel, Valerie ;
Rigaud, Charlotte ;
Plante-Bordeneuve, Violaine ;
Bodez, Diane ;
Mohty, Dania .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (03) :194-202
[3]   Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality [J].
Donnellan, Eoin ;
Wazni, Oussama M. ;
Saliba, Walid I. ;
Baranowski, Bryan ;
Hanna, Mazen ;
Martyn, Michael ;
Patel, Divyang ;
Trulock, Kevin ;
Menon, Venu ;
Hussein, Ayman ;
Aagaard, Philip ;
Jaber, Wael ;
Kanj, Mohamed .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (11) :2427-2432
[4]   Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis [J].
Hamon, David ;
Algalarrondo, Vincent ;
Gandjbakhch, Estelle ;
Extramiana, Fabrice ;
Marijon, Eloi ;
Elbaz, Nathalie ;
Selhane, Dounia ;
Dubois-Rande, Jean-Luc ;
Teiger, Emmanuel ;
Plante-Bordeneuve, Violaine ;
Damy, Thibaud ;
Lellouche, Nicolas .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 :562-568
[5]   Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death [J].
Kristen, Arnt V. ;
Dengter, Thomas J. ;
Hegenbart, Ute ;
Schonland, Stefan O. ;
Goldschmidt, Hartmut ;
Sack, Falk-Udo ;
Voss, Frederik ;
Becker, Rudiger ;
Katus, Hugo A. ;
Bauer, Alexander .
HEART RHYTHM, 2008, 5 (02) :235-240
[6]   Cardiac amyloidosis: Updates in diagnosis and management [J].
Mohty, Dania ;
Damy, Thibaud ;
Cosnay, Pierre ;
Echahidi, Najmeddine ;
Casset-Senon, Danielle ;
Virot, Patrice ;
Jaccard, Arnaud .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (10) :528-540
[7]   2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [J].
Ponikowski, Piotr ;
Voors, Adriaan A. ;
Anker, Stefan D. ;
Bueno, Hector ;
Cleland, John G. F. ;
Coats, Andrew J. S. ;
Falk, Volkmar ;
Ramon Gonzalez-Juanatey, Jose ;
Harjola, Veli-Pekka ;
Jankowska, Ewa A. ;
Jessup, Mariell ;
Linde, Cecilia ;
Nihoyannopoulos, Petros ;
Parissis, John T. ;
Pieske, Burkert ;
Riley, Jillian P. ;
Rosano, Giuseppe M. C. ;
Ruilope, Luis M. ;
Ruschitzka, Frank ;
Rutten, Frans H. ;
van der Meer, Peter .
EUROPEAN HEART JOURNAL, 2016, 37 (27) :2129-U130
[8]   Cardiac resynchronization therapy in a patient with amyloid cardiomyopathy [J].
Zizek, David ;
Cvijic, Marta ;
Zupan, Igor .
ACTA CARDIOLOGICA, 2013, 68 (03) :335-337